Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Baxter Healthcare Corporation recalls Regadenoson Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Labeling: Missing Label
Products
  • Regadenoson Injection
Where it was sold

Nationwide within the USA

Nationwide

Units affected
60,594 units
About this recall
Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01